Enrichment of circulating melanoma cells (CMCs) using negative selection from patients with metastatic melanoma.

Oncotarget · 2014 · PMC4058018 · PMID 24811334

Europe PMC DOI

hedged sentence

0.1200

closest p · 2.4× alpha

0.1200

boldest claim

The sentences

a negative trendp = 0.12not close (p > 0.1)

Nevertheless, preliminary analysis of the overall survival based on the CMC counts within our tested cohort of patients indicated a negative trend between survival and CMC counts in all patients (p = 0.12) and particularly for BRAF V600E cutaneous melanoma patients (p = 0.06).

also in 4,201 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.